This case examines the microeconomic pricing related to the sale of inexpensive vaccines for use in developing countries. Thing to describe the historical success of the United Nations so-called "tiered pricing" policy. This policy has allowed the World Health Organization to purchase large volumes of vaccine on the marginal production cost of vaccines, often only a few cents per dose, while the developed countries paid full average cost, often many times more. Changing political situation and the cost structure of new vaccines threatens decades of agreement, however. HKS Case Number 1450.0 "Hide
by Susan Rosegrant 7 pages. Publication Date: November 1, 1997. Prod. #: HKS602 -PDF-ENG
Related Case Solutions & Analyses:
Internal Branding at Yahoo: Crafting the Employee Value Proposition
Using Corporate Social Responsibility as Insurance for Financial Performance
Capitalism and Democracy in a New World
Purinex Inc.
The Early-Stage Term Sheet
Birth of Modern Macroeconomic Policy: Sweden and the Great Depression
Chinas Telecommunications Sector
U.S. Airline Industry in 1995
India in the 1990s
American Repertory Theatre–1988
